Global Wound Care Congress September 12-13 2016
San Antonio, Texas, USA

Dr. Thomas E. Serena MD FACS, Founder and Medical Director of SerenaGroupâ„¢, a family of wound, hyperbaric and research companies. Dr. Serena completed his residency in Surgery at the Hershey Medical Center. To date he has opened and operates wound care centers across the United Sates and globally. He has been the lead or Principal investigator in over 100 clinical trials and is recognized internationally as an expert in the field of wound healing: He has more than 100 published papers and has given more than 1000 invited lectures throughout the world. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now the President-Elect. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association

• Hyperbaric Oxygen therapy in the treatment of any of the 14 approved indications • Amputation prevention • The business of wound care • Research in wound healing • Diagnostics in wound healing • Indocyanine Green Fluorescent Angiography in wound healing • Advanced wound care

Dr. Gerlach was recruited to the University of Pittsburgh after the Washington-based non-profit World Technology Evaluation Center (WTEC) report, “Tissue Engineering and Research 2002", identified him as one of the experts worldwide addressing 3-D perfusion high-density culture design for medical devices. Dr. Gerlach holds an MD and two PhDs with a background in surgery, experimental surgery, and bioengineering. With his dual appointment, he directs the interdisciplinary Bioreactor Group at the McGowan Institute for Regenerative Medicine within the University of Pittsburgh and contributes to the Schools of Medicine and Engineering. Most of his projects focus on cell biology methodology and bioengineering technology developments are designed to contribute to knowledge on controlling cell behavior for anticipated patient treatments. His working hypotheses, consequently, relates mostly to the behavior and function of progenitor cells in an in vitro environments that he developed. Dr. Gerlach´s general interest is in technologies for the clinical translation of stem cell biology research, and he concentrates on the development of innovative cell-based therapies. In the area of skin he developing active wound dressings and cell spray grafting technologies. His “Skin Gun” development was broadcasted on National Geographic TV and is posted on YouTube under the key word “skin gun”.

Dr.Gerlach's research focus is on improving the understanding of how to control the expansion and differentiation of stem cells on a clinical translation scale. Organs and cells of interest have been skin, liver, bone marrow and hematopoietic, neuronal, adipose tissue, and cancer cells. He works with adult progenitors, fetal tissue derived progenitors, and embryonal stem cell lines. He specializes in advancing 2-D in vitro culture models to 3-D perfusion high-density cell-co-culture systems for stem cells, development of bioreactors for organ support, and systems for the production of cells for regenerative medicine cell transplantation. General topics include maintenance and differentiation of cells in vitro for extracorporeal, temporary clinical use as a hybrid organ, in vitro models for studies on stem cell niche interactions, and production of cells in cell-based therapy.

Brian Peskin, BSEE-MIT (1979), is a theoretical research scientist specializing in lipids‐based pharmacognosy, and CEO of Peskin Pharmaceuticals. His research focuses specifically on physiologically targeted essential fatty acids (EFAs) and their eicosanoid metabolites. Being a translational science expert with a long-term interest in diabetes and its underlying pathophysiology, extensive work in oncology and cardiology preceeded his applications into diabetic foot ulcers. His work is focused on pathways maximizing oxygen delivery and blood flow to the human cell and maximizing tissue functionality. Focus is on supporting and optimizing the patient's natural physiologic processes—not blocking or impeding metabolic pathways.

His research focuses specifically on physiologically targeted essential fatty acids (EFAs) and their eicosanoid metabolites. Being a translational science expert with a long-term interest in diabetes and its underlying pathophysiology, extensive work in oncology and cardiology preceeded his applications into diabetic foot ulcers/wounds.

Dr. Chaur-Dong Hsu received his medical degree from Kaohsiung Medical School in Kaohsiung, Taiwan, in 1982, and his master of public health degree from The John Hopkins University School of Hygiene and Public Health in Baltimore, MD., in 1991. Currently, he is Chairman and Frank P. Iacobell Endowed Professor of Department of Obstetrics and Gynecology, Wayne State University School of Medicine; Program Director and Principal Investigator of Women’s Reproductive Health Research Career Development, National Institutes of Health (NIH); Specialist-in-Chief, OB/GYN, Hutzel Women's Hospital/Detroit Medical Center and Chief of OB/GYN at Barbara Ann Karmano Cancer Institute.

Obstetrics and Gynecology, Surgical site Infection control, Maternal-Fetal Medicine,Hygiene and Public Health

Born in Los Angeles, Ronald Sherman earned his BS in Entomology at UC Riverside, his MD at UCLA, and his Masters degree in Clinical Tropical Medicine at the University of London, School of Hygiene and Tropical Medicine. He completed his Internship at Mt. Zion Hospital & Medical Center (one of the UC San Francisco training hospitals) in 1984, his Internal Medicine Residency at UC Davis in 1987 and his Infectious Diseases Fellowship at UC Irvine in 1991. Dr. Sherman started studying myiasis and maggot therapy during medical school, published his first paper on the topic in 1983, and started the first prospective studies in 1990. Twenty years ago, Dr. Sherman published his laboratory methods, so that maggot laboratories could develop throughout the world and supply local populations with medicinal maggots. There are now approximately 22 independent laboratories around the world producing medicinal maggots. After 4 years working for the Veterans Affairs Medical Center (Long Beach, CA) as an infectious diseases and geriatrics specialist, Dr. Sherman joined the faculty of the University of California in 1995, where he continued his research in myiasis and maggot therapy. Requests for Dr. Sherman’s medical grade maggots increased world-wide, and in 2004, after review of Dr. Sherman’s clinical studies, the FDA granted full marketing clearance for his Medical Maggots. In order to comply with the high manufacturing standards of the FDA, the laboratory (now known as Monarch Labs) separated from the University in 2005, and Dr. Sherman left the University himself in 2008 to oversee that laboratory, and to continue directing the BioTherapeutics, Education & Research (BTER) Foundation, a non-profit, member-supported organization dedicated to advancing health care through education and research in the therapeutic use of living animals. To minimize conflicts of interest, Dr. Sherman does not accept salary for his work for Monarch Labs nor the BTER Foundation, and he donates all speaking honoraria to the Foundation. To support his family, Dr. Sherman works 1 - 2 days/week as an HIV / AIDS Specialist for the Orange County health department.

Maggot therapy, Leech therapy, and the many other Biotherapeutic modalities

Dr. Efraim Jaul is a specialist in Family Medicine and Geriatric Medicine. He is the Head of the Geriatric Skilled Nursing Department at the Sarah Herzog Hospital, Jerusalem, Israel. It is affiliated with the Hebrew University-Hadassah Medical School, Jerusalem. He is a Clinical Senior Lecturer in the Hebrew Medical School Faculty. He teaches medical students as well as nursing students at the Academic Nursing schools of Hadassah Hospital (Jerusalem), Kaplan Hospital (Rechovot), Ichilov Hospital (Tel Aviv), and Jerusalem College of Technology (Jerusalem). He supervises clinical practice and mentors students. He developed and established a pioneering inpatient unit at the Herzog Hospital specifically for the treatment of pressure ulcers concerning the need for a special unit and the resulting benefits for the immobile elderly patients. This unit has elicited interest in serving as a model for geriatric treatment facilities around the world and has set the standard for developing specialized pressure ulcer units.

The primary concept behind the pressure ulcers is the idea that pressure ulcers do not occur alone, and are an integral part of the clinical assessment and preventive treatment of the geriatric patient became a guiding principle in all of his work. It is important to attend not only to the pressure ulcers but also the general needs of the patient. This approach was summarized by Dr. Jaul in an article entitled "Non-Healing Wounds The Geriatric Approach" and a review article about " Assessment and Management of Pressure Ulcers in the Elderly Patients Current Strategy ". This leading essay highlights multi-factorial risks and treatment involved in Multidisciplinary and Comprehensive Approaches to Optimal Management of Pressure Ulcers in the Elderly. Dr. Jaul coined a new terminology in the field of pressure ulcers "atypical pressure ulcers", based on location and etiology classified medical devices, bone deformation and severe spasticity. He was a stream planner for the scientific program of Pressure Ulcers in the 4th Congress of World Union Wound Healing Societies (WUWHS 2012) in Yokohama, Japan. Currently, he is investigating comorbidities focusing on advanced dementia and other comorbidity on pressure ulcers to understand the underlying pathogenesis

Dr. Angela Peghetti is the A.I.S.LE.C. President. She performs coordinative and organisational tasks within different fields: scientific committees, administrative office organizations, institutions and media. In collaboration with the relevant bodies, she draws up projects, deals with paperwork, budget and balance sheets for the same Society. She is Professor and lecturer in the Tor Vergata University of Roma and Bicocca University of Milano. She works in Solatrix hospital in Rovereto (Italy) and focuses on developing Education, Research, Data Collection, alongside organising the research and updating of practice recommendations in the field of wound care.

wound care, biofilms in clinical practice

Dr nidal Younes has completed his MD from Jordan University and postdoctoral studies at the University of Chicago School of Medicine. He is the director of foot clinic at the national center for diabetes, endocrine and genetics, an endocrine surgeon at the JUH.

Diabetic Foot Ulcers, Endocrinology and Genetics

Dr Hamilton completed his PhD in Cellular Engineering at the University of Glasgow in 2000. He worked as a Research Scientist with Advanced Medical Solutions PLC., in England, followed by Postdoctoral studies at the McGowan Institute for Regenerative Medicine, University of Pittsburgh and at the University of British Columbia, Vancouver. He established his independent laboratory at the University of Western Ontario in 2007, which is focused on biomaterials and connective tissue repair. He has published 39 original research articles, and serves as an editorial board member for the Journal of Cell Communication & Signaling and The Journal of Cytology & Histology

Non-healing skin wounds, Wound Therapy and Wound Management

Onnen Grauhan is professor of cardiovascular surgery at the Charite`, Humboldt University Berlin and consultant surgeon at the Department of Cardiothoracic and Vascular Surgery at Deutsches Herzzentrum Berlin, Germany.

Cardiovascular surgery, Wound mannagement, Nagative pressire therapy

Michele (Shelly) Burdette-Taylor has completed her PhD at the University of San Diego in California. She is an assistant professor at the University of Alaska Anchorage. She teaches undergraduate and graduate courses in community health, foot care, and wound care for the college of health, school of nursing and physician assistant program. She has published numerous skin, wound, pressure ulcer, and foot care articles. Her most recent publication was a chapter for the new Wound Ostomy Continence Nurses Core Curriculum for Wound Care for entitled Foot and Nail Care.

Lower extremity wounds

Mieczyslawa Franczyk has completed her master's degree in PT and post graduated study for PhD from University of Physical Education in Poland. She graduated from University of Illinois Public School of Health. She is a member of American Physical Therapy Association. She is author or co-author 8 papers, 7 in arena of subatmospheric pressure wound therapy

Subatmospheric pressure wound therapy , Fistulae management, Wound Mangement and Therapy

Jasmina Begic finished postgraduate study on the Sarajevo University Medical School of Medicine. She is Medical Consultant for BIOPTRON, Zepter Internastional for Bosnia and Herzegovina , Founder of Association for Wound management in B&H, Founder and author of Euro-Asian Forum, one of founder of www.BALWMA.org. She is member of EWMA Cooperating Organisations Board.

Wound Management, Wound Healing, Advance wound treatments